Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


BMS/Thermocore pact for vulnerable plaque

This article was originally published in The Gray Sheet

Executive Summary

Bristol-Myers Squibb gains worldwide development, manufacturing and commercialization rights to Thermocore intracoronary thermographic catheter system technology designed to detect vulnerable plaque by mapping temperature variations inside coronary arteries. Rupture of vulnerable plaque is a prime cause of heart attack. Initial clinical trials will focus on assessing the prognostic value of the device, according to BMS. During a vulnerable plaque summit at the May CRT 2004 conference in Washington, D.C., participants generally agreed that no accurate imaging tools currently exist to detect vulnerable plaque 1"The Gray Sheet" May 10, 2004, p. 4)...

You may also be interested in...

DES For Vulnerable Plaque: Consensus Elusive With Current Imaging Tools

Drug-eluting stents should not be viewed as the definitive treatment for vulnerable plaque, according to David Holmes, MD, Mayo Clinic

Moderna Marches First Coronavirus Vaccine To US Test

The first vaccine for the new coronavirus has entered the clinic, with US firm Moderna leading the race.

SK Bio Begins New Coronavirus Vaccine Development Using Versatile Platform

Korean vaccine specialist SK Bioscience moves to develop versatile platform technology to deal with outbreaks of infectious diseases such as the new coronavirus, as the number of infections in the country surges.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts